This article has Open Peer Review reports available.
The allosteric AKT inhibitor MK2206 shows a synergistic interaction with chemotherapy and radiotherapy in glioblastoma spheroid cultures
© The Author(s). 2017
Received: 13 October 2016
Accepted: 11 March 2017
Published: 21 March 2017
Open Peer Review reports
Pre-publication versions of this article and author comments to reviewers are available by contacting firstname.lastname@example.org.
|13 Oct 2016||Submitted||Original manuscript|
|14 Dec 2016||Reviewed||Reviewer Report - Nadia Zaffaroni|
|20 Dec 2016||Reviewed||Reviewer Report - Ratna Vadlamudi|
|20 Jan 2017||Author responded||Author comments - Ravi Narayan|
|Resubmission - Version 2|
|20 Jan 2017||Submitted||Manuscript version 2|
|23 Jan 2017||Reviewed||Reviewer Report - Ratna Vadlamudi|
|6 Feb 2017||Reviewed||Reviewer Report - Nadia Zaffaroni|
|21 Feb 2017||Author responded||Author comments - Ravi Narayan|
|Resubmission - Version 3|
|21 Feb 2017||Submitted||Manuscript version 3|
|3 Mar 2017||Author responded||Author comments - Ravi Narayan|
|Resubmission - Version 4|
|3 Mar 2017||Submitted||Manuscript version 4|
|11 Mar 2017||Editorially accepted|
|21 Mar 2017||Article published||10.1186/s12885-017-3193-9|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting email@example.com. All previous versions of the manuscript and all author responses to the reviewers are also available.
You can find further information about the peer review system here.